Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9,403.50%-2.14M | -103,016.50%-1.69M | 90.86%-1.76K | 30.55%-74.81K | 47.88%-31.43K | -103.08%-22.52K | 96.95%-1.64K | -211.35%-19.22K | -15.37%-107.71K | -214.81%-60.31K |
| Net income from continuing operations | -11,891.62%-2.32M | -11,023.99%-1.11M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Operating gains losses | ---8.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.53%-35.41K | ---- |
| Depreciation and amortization | --3.83K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | --354.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -5,241.91%-169.02K | -8,209.96%-680.02K | 3,519.44%204.46K | 21,126.35%346.3K | 442.86%335.44K | 13.97%-3.16K | 753.87%8.39K | -94.29%5.65K | -113.63%-1.65K | -65.32%-97.83K |
| -Change in prepaid assets | ---449.58K | ---379.53K | ---26.87K | --0 | --0 | --0 | --0 | --0 | 4.10%2.11K | --0 |
| -Change in payables and accrued expense | 8,967.38%280.56K | -3,683.69%-300.49K | 3,995.03%231.33K | 9,322.48%346.3K | 442.86%335.44K | 13.97%-3.16K | 753.87%8.39K | -94.16%5.65K | -137.34%-3.76K | -50.22%-97.83K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9,403.50%-2.14M | -103,016.50%-1.69M | 90.86%-1.76K | 30.55%-74.81K | 47.88%-31.43K | -103.08%-22.52K | 96.95%-1.64K | -211.35%-19.22K | -15.37%-107.71K | -214.81%-60.31K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -42.39K | |||||||||
| Net PPE purchase and sale | ---42.39K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---42.39K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5.25M | -452.89K | 13,978.91%4.58M | -113.90%-33K | 0 | 0 | 0 | -82.22%-33K | 176.17%237.33K | 0 |
| Net issuance payments of debt | ---19.99K | ---473.1K | 80.39%-100K | 25.00%-510K | --0 | --0 | --0 | -168.42%-510K | -891.29%-680K | --0 |
| Net common stock issuance | --4.67M | ---- | ---- | --0 | --0 | --0 | ---- | --0 | --917.33K | --0 |
| Proceeds from stock option exercised by employees | --752.08K | --0 | --0 | --477K | --0 | --0 | --0 | --477K | --0 | --0 |
| Net other financing activities | ---- | ---4.54M | --4.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --5.25M | ---452.89K | 13,978.91%4.58M | -113.90%-33K | --0 | --0 | --0 | -82.22%-33K | 176.17%237.33K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 2,332.05%1.92M | 5,619.65%4.6M | -81.24%24.9K | 4,197.38%132.7K | -70.82%56.33K | -59.38%78.84K | 3,491.25%80.48K | 4,197.38%132.7K | -70.62%3.09K | 2,540.41%193.01K |
| Current changes in cash | 13,741.05%3.07M | -164,060.94%-2.69M | 8,866.79%4.58M | -183.18%-107.81K | 47.88%-31.43K | -1,971.39%-22.52K | -100.85%-1.64K | -6,065.64%-52.22K | 1,846.36%129.62K | -1,328.49%-60.31K |
| End cash Position | 8,757.07%4.99M | 2,332.02%1.92M | 5,619.65%4.6M | -81.24%24.9K | -81.24%24.9K | -70.82%56.33K | -59.38%78.84K | 3,491.25%80.48K | 4,197.38%132.7K | 4,197.38%132.7K |
| Free cash from | -9,591.74%-2.18M | -136,378.24%-2.23M | 90.86%-1.76K | 30.55%-74.81K | 47.88%-31.43K | -103.08%-22.52K | 96.95%-1.64K | -211.35%-19.22K | -15.37%-107.71K | -214.81%-60.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.